User profiles for Adam C Naj
Adam NajSenior Scholar, CCEB, University of Pennsylvania Perelman School of Medicine Verified email at mail.med.upenn.edu Cited by 11737 |
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Risk for late-onset Alzheimer’s disease (LOAD), the most prevalent dementia, is partially
driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association …
driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association …
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
…, JD Burgess, V Solfrizzi, P Proitsi, HH Adams… - Nature …, 2017 - nature.com
We identified rare coding variants associated with Alzheimer's disease in a three-stage case–control
study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole-…
study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole-…
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous
studies; however, a large portion of the genetic risk for this disease remains unexplained. …
studies; however, a large portion of the genetic risk for this disease remains unexplained. …
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …
Genomic variants, genes, and pathways of Alzheimer's disease: An overview
AC Naj, GD Schellenberg… - American Journal of …, 2017 - Wiley Online Library
Alzheimer's disease (AD) (MIM: 104300) is a highly heritable disease with great complexity
in its genetic contributors, and represents the most common form of dementia. With the …
in its genetic contributors, and represents the most common form of dementia. With the …
[HTML][HTML] New insights into the genetic etiology of Alzheimer's disease and related dementias
…, JE Below, P Benchek, L Benussi, C Berr, C Besse… - Nature …, 2022 - nature.com
Abstract Characterization of the genetic landscape of Alzheimer’s disease (AD) and related
dementias (ADD) provides a unique opportunity for a better understanding of the associated …
dementias (ADD) provides a unique opportunity for a better understanding of the associated …
[HTML][HTML] Assessment of the genetic variance of late-onset Alzheimer's disease
…, GD Schellenberg, JSK Kauwe, PM Adams… - Neurobiology of …, 2016 - Elsevier
Alzheimer's disease (AD) is a complex genetic disorder with no effective treatments. More
than 20 common markers have been identified, which are associated with AD. Recently, …
than 20 common markers have been identified, which are associated with AD. Recently, …
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes
Objectives: To determine whether genotypes at CLU, PICALM, and CR1 confer risk for
Alzheimer disease (AD) and whether risk for AD associated with these genes is influenced by …
Alzheimer disease (AD) and whether risk for AD associated with these genes is influenced by …
Novel Alzheimer disease risk loci and pathways in African American individuals using the African genome resources panel: a meta-analysis
Importance Compared with non-Hispanic White individuals, African American individuals
from the same community are approximately twice as likely to develop Alzheimer disease. …
from the same community are approximately twice as likely to develop Alzheimer disease. …
[HTML][HTML] Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias
Alzheimer's disease (AD) and related dementias are a major public health challenge and
present a therapeutic imperative for which we need additional insight into molecular …
present a therapeutic imperative for which we need additional insight into molecular …